racemetirosine has been researched along with Chronic Disease in 4 studies
alpha-Methyltyrosine: An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pol, O | 1 |
| Campmany, L | 1 |
| Armario, A | 1 |
| Abi-Dargham, A | 1 |
| Rodenhiser, J | 1 |
| Printz, D | 1 |
| Zea-Ponce, Y | 1 |
| Gil, R | 1 |
| Kegeles, LS | 1 |
| Weiss, R | 1 |
| Cooper, TB | 1 |
| Mann, JJ | 1 |
| Van Heertum, RL | 1 |
| Gorman, JM | 1 |
| Laruelle, M | 1 |
| Nisenbaum, LK | 1 |
| Abercrombie, ED | 1 |
| Caldecott-Hazard, S | 1 |
| Mazziotta, J | 1 |
| Phelps, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Imaging Cannabinoid CB1 Receptors in Schizophrenia[NCT01063335] | 1 participants (Actual) | Observational | 2010-02-01 | Terminated | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 other studies available for racemetirosine and Chronic Disease
| Article | Year |
|---|---|
Inhibition of catecholamine synthesis with alpha-methyl-p-tyrosine apparently increases brain serotoninergic activity in the rat: no influence of previous chronic immobilization stress.
Topics: Acute Disease; alpha-Methyltyrosine; Animals; Brain Chemistry; Catecholamines; Chronic Disease; Enzy | 1995 |
Increased baseline occupancy of D2 receptors by dopamine in schizophrenia.
Topics: Adult; alpha-Methyltyrosine; Antipsychotic Agents; Chronic Disease; Corpus Striatum; Dopamine; Femal | 2000 |
Enhanced tyrosine hydroxylation in hippocampus of chronically stressed rats upon exposure to a novel stressor.
Topics: alpha-Methyltyrosine; Animals; Chronic Disease; Dihydroxyphenylalanine; Extracellular Space; Hippoca | 1992 |
Cerebral correlates of depressed behavior in rats, visualized using 14C-2-deoxyglucose autoradiography.
Topics: alpha-Methyltyrosine; Amphetamine; Animals; Autoradiography; Behavior, Animal; Brain; Carbon Radiois | 1988 |